The SME IPO market in India continues to attract strong investor attention, and the Q-Line Biotech IPO GMP today 2026 is becoming one of the most searched topics among IPO investors. With a strong grey market premium (GMP), growing subscription interest, and positive market sentiment, Q-Line Biotech IPO is currently gaining traction in the primary market.
In this article, we cover the Q-Line Biotech IPO GMP live updates, IPO dates, price band, subscription status, expected listing price, company overview, and complete review and analysis for investors.
Q-Line Biotech IPO Details 2026
Q-Line Biotech IPO is a book-built SME IPO issue worth approximately ₹214.48 crore. The IPO consists entirely of a fresh issue of shares, helping the company raise funds for business expansion and corporate purposes.
Q-Line Biotech IPO Important Dates
| Particulars | Details |
| IPO Opening Date | May 21, 2026 |
| IPO Closing Date | May 25, 2026 |
| Allotment Date | May 26, 2026 |
| Refund Initiation | May 27, 2026 |
| Shares Credit Date | May 27, 2026 |
| Listing Date | May 29, 2026 |
| Listing Exchange | NSE SME |
Q-Line Biotech IPO Price Band and Lot Size
The company has fixed the IPO price band at ₹326 to ₹343 per share.
| IPO Information | Details |
| Face Value | ₹10 per share |
| Price Band | ₹326 – ₹343 |
| Lot Size | 400 Shares |
| Minimum Retail Investment | ₹2,74,400 |
| HNI Minimum Investment | ₹4,11,600 |
| Issue Type | Book Build Issue |
| Total Issue Size | ₹214.48 Crore |
The minimum investment amount is comparatively higher because investors must apply for at least two lots in the retail category.
Q-Line Biotech IPO GMP Today 2026
The Q-Line Biotech IPO GMP today 2026 indicates strong investor sentiment in the grey market. Grey market premium is an unofficial indicator showing expected listing gains before the stock gets listed on the exchange.
Q-Line Biotech SME IPO Day-wise GMP Trend
| Date | IPO Price | GMP | Expected Listing Price | Estimated Gain |
| 19 May 2026 | ₹343 | ₹95 | ₹438 | 27.70% |
| 18 May 2026 | ₹343 | ₹69 | ₹412 | 20.12% |
| 17 May 2026 | ₹343 | ₹0 | ₹343 | 0% |
As per the latest Q-Line Biotech IPO grey market premium today, the GMP has increased significantly from ₹69 to ₹95, indicating positive market demand.
However, investors should remember that GMP is unofficial and can change rapidly depending on market conditions.
Q-Line Biotech IPO Expected Listing Price 2026
Based on the current GMP trend, the Q-Line Biotech IPO expected listing price 2026 is estimated around ₹430 to ₹440 per share.
If the current premium sustains till listing day, investors may expect decent listing gains. However, listing performance also depends on broader market sentiment, subscription demand, and institutional participation.
Estimated Listing Scenario
- Upper Price Band: ₹343
- Current GMP: ₹95
- Expected Listing Price: ₹438
- Expected Listing Gain: Nearly 28%
These figures are only estimates and actual listing prices may vary.
Q-Line Biotech IPO Subscription Status Today
The Q-Line Biotech IPO subscription status today will be closely watched by retail investors, HNIs, and SME market participants.
A strong subscription generally indicates:
- High investor demand
- Positive market confidence
- Better chances of strong listing performance
Since the IPO opens on May 21, 2026, investors are expected to monitor category-wise subscription data daily for:
- Retail Individual Investors (RII)
- Non-Institutional Investors (NII)
- Qualified Institutional Buyers (QIB)
Strong subscription in the HNI category often boosts GMP momentum in SME IPOs.
Q-Line Biotech IPO Review and Analysis 2026
The Q-Line Biotech IPO review and analysis 2026 appears positive based on current market trends and GMP performance.
Positive Factors
- Strong GMP trend before IPO opening
- SME IPO market sentiment remains positive
- Entire issue is a fresh issue, supporting company growth
- Healthy expected listing premium
Risk Factors
- SME IPOs are highly volatile
- GMP is unofficial and speculative
- Higher minimum investment amount for retail investors
- Post-listing liquidity can sometimes be limited
Investors should carefully evaluate company fundamentals, financials, business model, and risk appetite before applying.
Should You Apply for Q-Line Biotech IPO?
The strong Q-Line Biotech IPO GMP live updates indicate good investor interest in the IPO. The increasing grey market premium also reflects positive expectations regarding listing gains.
Short-term listing gain investors may find the IPO attractive due to:
- Rising GMP trend
- Positive SME market momentum
- Expected premium listing
Long-term investors should additionally analyze:
- Company financial performance
- Revenue growth
- Profit margins
- Industry opportunities
- Valuation at upper price band
Final Thoughts
The Q-Line Biotech IPO GMP today 2026 continues to remain strong ahead of the IPO opening date. With a latest GMP of around ₹95 and an estimated listing price near ₹438, market sentiment currently appears positive.
The IPO will open for subscription from May 21 to May 25, 2026, and is expected to list on NSE SME on May 29, 2026.
Investors should keep tracking:
- Q-Line Biotech IPO GMP live updates
- Subscription status
- Institutional participation
- Overall market conditions
As always, IPO investments carry risks, and GMP should not be the only factor considered before investing.
⚠️ Disclaimer
Investments in securities market are subject to market risks. Read all the related documents carefully before investing. This is only for informational purposes.
Angel One Ltd. is just acting as the distributor of the IPO. Investors are requested to do their due diligence before investing in any IPO. Investor grievance redressal mechanism of exchange would not be available for applying in IPO
📍 Registration Details
Angel One Limited (formerly known as Angel Broking Limited), Registered Office: 601, 6th Floor, Ackruti Star, Central Road, MIDC, Andheri East, Mumbai – 400093.
Tel: 080-47480048
CIN: L67120MH1996PLC101709
SEBI Regn. No.: INZ000161534
Compliance Officer: Mr. Bineet Jha
Tel: (022) 39413940
Email: compliance@angelbroking.com
📞 Contact 4R Investments
📍 3-1-309/310, Tara Kaushalya Nivas, Nimboliadda, Kachiguda, Hyderabad – 500027
📞 6300169336
📧 contact@4rinvestments.in
🌐 https://4rinvestments.in/